DoorDash soared as the top performer in the S&P 500 after announcing a partnership with Old Navy, while Bristol-Myers Squibb faced a downturn due to the termination of a clinical trial for an experimental heart medication. Major U.S. equities indexes closed mixed but ended the week with gains.

Morgan Stanley named Micron Technology a “top pick” with a price target increase, leading to a 4.2% rise in shares. Warner Bros. Discovery saw a 4% increase following reports of potential takeover offers from Paramount Skydance, Comcast, and Netflix for CNN and HBO. Netflix is also preparing for a 10-for-1 stock split.

Netflix’s stock dropped 3.6% ahead of its upcoming 10-for-1 stock split, which will begin trading on a split-adjusted basis on Monday. Bristol-Myers Squibb stock fell 4.1% after discontinuing a late-stage clinical trial for the heart treatment milvexian developed with Johnson & Johnson.

Read more at Yahoo Finance: DoorDash Drives Higher on a New Partnership; Bristol-Myers Squibb Stock Falls